feed,title,long_url,short_url
Investors,Travere Stock Pops After Snagging Full Approval For Calliditas Rival In Kidney Disease,https://www.investors.com/news/technology/travere-therapeutics-filspari-approval/,https://da.gd/7XLVm1
